Wednesday's NASDAQ Winners: OREX, FLML, MATR, JASO

POINT ROBERTS - September 22, 2011 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on top percentage gainers on the NASDAQ for Wednesday September 21st. NASDAQ closed lower by -52.05 (-2.01%) to 2538.19.

Orexigen Therapeutics, Inc. (NASDAQ:OREX) was the top percentage gainer for the session closing higher by 0.72 (48.98%) to $2.19 after the company said that it is renewing development of the experiment obesity drug Contrave after reaching an agreement with U.S. regulators to further study heart risks.
Flamel Technologies (NASDAQ:FLML) surged 0.82 (18.34%) to close at $5.29 on major news. The stock has soared 33% over the past one week. It has a 52-week range of $4.50-$5.43.
Mattersight (NASDAQ:MATR) closed with an impressive gain of 0.62 (14.00%) to end the day at $5.05 extending its previous session rally of 4.50%. The stock is still down over 77% so far this year.
JA Solar Holdings (NASDAQ:JASO) ended at $2.25, up 0.25 (12.50%) on no news. The stock rallied following a 32% fall in the previous one week. The stock made a new 52-week low of $2.00 on Tuesday. So far this year, the stock has lost two third of its market capitalization.
Investor Research Tools;
Get Free investor news and stock alerts
Sign Up: http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas Get 13 of the best stock directories online;
Research oil and gas stocks, gold stocks, water stocks, renewable energy stocks (over 1300 green stocks in directory) and more
Join: http://www.investorideas.com/membership/
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising . www.InvestorIdeas.com/About/Disclaimer.asp
800-665-0411
Source - www.Investorideas.com